STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
210.83
-2.87 (-1.34%)
May 8, 2026, 10:48 AM EDT - Market open
STERIS Revenue
STERIS had revenue of $1.50B in the quarter ending December 31, 2025, with 9.16% growth. This brings the company's revenue in the last twelve months to $8.68B, up 8.40% year-over-year. In the fiscal year ending March 31, 2025, STERIS had annual revenue of $10.92B with 6.24% growth.
Revenue (ttm)
$8.68B
Revenue Growth
+8.40%
P/S Ratio
3.60
Revenue / Employee
$327,656
Employees
17,787
Market Cap
20.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.92B | 641.60M | 6.24% |
| Mar 31, 2024 | 10.28B | 1.20B | 13.28% |
| Mar 31, 2023 | 9.07B | 625.72M | 7.41% |
| Mar 31, 2022 | 8.45B | 5.34B | 171.82% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | 3.03B | 248.73M | 8.94% |
| Mar 31, 2019 | 2.78B | 162.17M | 6.19% |
| Mar 31, 2018 | 2.62B | 7.24M | 0.28% |
| Mar 31, 2017 | 2.61B | 374.00M | 16.71% |
| Mar 31, 2016 | 2.24B | 388.50M | 21.00% |
| Mar 31, 2015 | 1.85B | 228.01M | 14.06% |
| Mar 31, 2014 | 1.62B | 120.35M | 8.01% |
| Mar 31, 2013 | 1.50B | 95.09M | 6.76% |
| Mar 31, 2012 | 1.41B | 199.36M | 16.51% |
| Mar 31, 2011 | 1.21B | -50.28M | -4.00% |
| Mar 31, 2010 | 1.26B | -40.80M | -3.14% |
| Mar 31, 2009 | 1.30B | 33.44M | 2.64% |
| Mar 31, 2008 | 1.27B | 67.68M | 5.65% |
| Mar 31, 2007 | 1.20B | 37.12M | 3.20% |
| Mar 31, 2006 | 1.16B | 78.62M | 7.27% |
| Mar 31, 2005 | 1.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GE HealthCare Technologies | 20.98B |
| Koninklijke Philips | 20.34B |
| Zimmer Biomet Holdings | 8.41B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
| DexCom | 4.82B |
| Globus Medical | 3.10B |
| Insulet | 2.90B |
STE News
- 18 hours ago - STERIS Appoints Pierre Boulud to Board of Directors - GlobeNewsWire
- 2 days ago - STERIS Announces Dividend of $0.63 per share - GlobeNewsWire
- 16 days ago - STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026 - GlobeNewsWire
- 3 months ago - STERIS Earnings Call Transcript: Q3 2026 - Transcripts
- 3 months ago - Steris sees FY26 adjusted EPS $10.15-$10.30, consensus $10.21 - TheFly
- 3 months ago - Steris reports Q3 adjusted EPS $2.53, consensus $2.53 - TheFly
- 3 months ago - STERIS Announces Financial Results for Fiscal 2026 Third Quarter - GlobeNewsWire
- 3 months ago - STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026 - GlobeNewsWire